A biotechnology company that claimed tax credits for increasing its scientific research improperly excluded $26.6 million in clinical testing expenses from its baseline calculation, juicing its claim by $1.2 million, the Internal Revenue Service told the Fourth Circuit.
Biotech Co. Inflated R&D Claim By $1.2M, 4th Circ. Told
by usoftax_admin | Oct 17, 2023 | Tax News